Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38α MAP kinase

Kamaldeep Gill, Abhay K. Singh, Vaishali Kapoor, Lokesh Nigam, Rahul Kumar, Prasida Holla, Satya N. Das, Savita Yadav, Naidu Subbarao, Bidhu K. Mohanti, Sharmistha Dey

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Background The p38α MAP kinase pathway is involved in inflammation, cell differentiation, growth, apoptosis and production of pro-inflammatory cytokines TNF-α and IL-1β. The overproduction of these cytokines plays an important role in cancer. The aim of this work was to design a peptide inhibitor on the basis of structural information of the active site of p38α. Methods A tetrapeptide, VWCS as p38α inhibitor was designed on the basis of structural information of the ATP binding site by molecular modeling. The inhibition study of peptide with p38α was performed by ELISA, binding study by Surface Plasmon Resonance and anti-proliferative assays by MTT and flow cytometry. Results The percentage inhibition of designed VWCS against pure p38α protein and serum of HNSCC patients was 70.30 and 71.5%, respectively. The biochemical assay demonstrated the KD and IC 50 of the selective peptide as 7.22 × 10- 9 M and 20.08 nM, respectively. The VWCS as inhibitor significantly reduced viability of oral cancer KB cell line with an IC50 value of 10 μM and induced apoptosis by activating Caspase 3 and 7. Conclusions VWCS efficiently interacted at the ATP binding pocket of p38α with high potency and can be used as a potent inhibitor in case of HNSCC. General significance VWCS can act as an anticancer agent as it potentially inhibits the cell growth and induces apoptosis in oral cancer cell-line in a dose as well as time dependent manner. Hence, p38α MAP kinase inhibitor can be a potential therapeutic agent for human oral cancer.

Original languageEnglish
Pages (from-to)2763-2769
Number of pages7
JournalBiochimica et Biophysica Acta - General Subjects
Volume1830
Issue number3
DOIs
StatePublished - Mar 1 2013
Externally publishedYes

Keywords

  • Anticancer
  • Apoptosis
  • HNSCC
  • Tetrapeptide
  • p38α

Fingerprint Dive into the research topics of 'Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38α MAP kinase'. Together they form a unique fingerprint.

  • Cite this